Repligen Corporation

NASDAQ:RGEN

Medical - Instruments & Supplies

Healthcare
$172.67 -2.74%

-$3.66 today

Market cap
$11.04B
Beta
1.08
P/E (TTM)
142.4
EPS (TTM)
$0.91
52W Low $100.99High $175.77

Volume 1.30M

Average 1.08M

RGEN Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Repligen CorporationNASDAQ: RGEN

Short-term Debt · Q2 FY2026 · quarter ended Jun 2026

Short-term debt remains negative

Q2 FY2026 short-term debt was $0, compared with $0 a year earlier. Over 3 fiscal years it compounded at -57.7% a year.

Context

  • Short-term debt amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Short-term debt increased in 1 of the last 3 fiscal years.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$21.56M— YoY
Year agoJun 2025
$0— since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR-57.7%——
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
21.56M USD
Year-over-year change
—
4-year CAGR
-46.1%

Short-term Debt vs competitors

How RGEN compares with its peers on the latest reported figures

  • RGEN's Jun 2026 short-term debt of $0 is the lowest of the 9 companies compared; the peer median is $118.5M.
  • Short-term debt amounts to 0.0% of total assets for RGEN, versus a peer median of 1.3%.
RGEN Competitors Peer median
Short-term Debt for RGEN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$2.26B -40.8%-15.5%2.0%
BIOBio-Rad Laboratories, Inc.Jun 2026$400.7M +30723.1%+333.6%3.9%
AAgilent Technologies, Inc.Jul 2026$304M +415.3%+103.6%2.2%
TECHBio-Techne CorporationSep 2026$200M ——7.6%
AVTRAvantor, Inc.Jun 2026$37M -97.1%-56.1%0.3%
QGENQiagen N.V.Jun 2026$16.52M -97.0%—0.3%
BLFSBioLife Solutions, Inc.Mar 2026$2.5M -76.1%+40.2%0.6%
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$1.13M -79.3%+0.0%0.2%
RGENRepligen CorporationJun 2026$0 —-57.7%0.0%
Peer median (excluding RGEN) $118.5M-76.1%+20.1%1.3%

Competitors are the stored peer set for RGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents603.81M523.46M751.32M757.36M566.02M
Short-term Investments0100.3M00201.61M
Net Receivables117.42M116.25M124.16M134.12M158.59M
Inventory184.49M238.28M202.32M142.96M170.46M
Other Current Assets19.27M17.41M19.92M20.6M27.14M
Total Current Assets931.68M998.12M1.11B1.07B1.14B
Property, Plant & Equipment (Net)226.52M315.7M322.96M333.12M306.15M
Goodwill860.36M855.51M987.12M1.03B1.11B
Intangible Assets337.27M360.62M406.96M397.9M386.15M
Long-term Investments00000
Tax Assets1.9M840K1.53M749K694K
Other Non-current Assets615K815K1.28M868K4.91M
Total Non-current Assets1.43B1.53B1.72B1.76B1.81B
Total Assets2.36B2.53B2.83B2.83B2.95B
Account Payables36.2M27.55M19.56M32.13M30.01M
Short-term Debt255.26M284.62M69.45M021.56M
Tax Payables4.98M2.46M6.81M00
Deferred Revenue14.68M19.28M17.07M13.24M14.61M
Other Current Liabilities42.15M47.47M29.64M49.29M25.92M
Total Current Liabilities375.26M404.2M164.94M126.79M135.83M
Long-term Debt00510.14M525.57M542.21M
Deferred Tax Liabilities33.48M23M39.32M22.78M22.5M
Deferred Revenue (Non-current)00001.54M
Other Non-current Liabilities97.05M62.32M25.35M36.24M15.32M
Total Non-current Liabilities233.03M216.7M701.4M730.16M707.74M
Total Liabilities608.29M620.9M866.34M856.95M843.57M
Common Stock553K556K558K561K563K
Retained Earnings194.06M397.27M432.87M407.35M456.25M
Accumulated OCI(16.89M)(34.39M)(37.81M)(52.53M)(2.53M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.75B1.91B1.96B1.97B2.11B
Total Debt366.05M422.96M711.8M686.25M689.95M
Net Debt(237.76M)(100.5M)(39.52M)(71.11M)123.93M

Repligen Corporation

NASDAQ:RGEN

Intrinsic Alpha fair value

Locked

Current Price

$172.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.